메뉴바로가기 컨텐츠 바로가기
right menu background

호흡기알레르기내과 실험실
(Laboratory for pulmonary, allergy and critical care medicine)

대표 논문

장승훈 교수

  1. Choi WI, Yim JJ, Park J, Kim SC, Na MJ, Lee WY, Hong SB, Choi HS, Jang SH, Kim WJ, Jeon K, Kim JH, Choi JC, Lee CH, Kim CH, Kim JY. Clinical characteristics and outcomes of H1N1-associated pneumonia among adults in South Korea. Int J Tuberc Lung Dis. 2011;15(2):270-5.
  2. Lee YS, Oh YM, Shim TS, Kim WS, An JS, Choi CM, Jang SH. The clinical outcomes of photodynamic therapy in early lung cancer patients. Tuberc Respir Dis 2011;71(4):266-270
  3. Park JY, Jang SH, Kim HJ, Park YB, Kwon JH, Song HH, Lee KW, Kim JH, Kim JH, Park SH, Hwang YI, Kim DG, Jung KS. Predicting the treatment response using a direct sequencing method for EGFR in non-squamous, non-small cell lung cancer. Korean J Med. 2011;81(5):611-622
  4. Ryu JS, Choi CM, Yang SC, Song SY, Jeon YJ, Jang TW, Kim DJ, Hun Jang S, Yang SH, Lee MK, Lee KH, Jo HJ, Jang SJ, Kim YT, Cho JH, Choi YD, Nam HS, Kim HJ, Ju Suh Y. Prognostic effect of age on survival of patients with stage I adenocarcinoma of the lung. Tumori. 2012;98(1):99-104
  5. Choi CM, Yang SC, Jo HJ, Song SY, Jeon YJ, Jang TW, Kim DJ, Jang SH, Yang SH, Kim YD, Lee KH, Jang SJ, Kim YT, Kim DK, Chung DH, Kim L, Nam HS, Cho JH, Kim HJ, Ryu JS. Proteins involved in DNA damage response pathways and survival of stage I non-small-cell lung cancer patients. Ann Oncol. 2012;23(8):2088-93.
  6. Jang SH, Kim SY, Kim JH, Park S, Hwang YI, Kim DG, Jung KS. Timing of chemotherapy-induced neutropenia is a prognostic factor in patients with metastatic non-small-cell lung cancer: a retrospective analysis in gemcitabine-plus-platinum-treated patients. J Cancer Res Clin Oncol. 2013;139(3):409-17
  7. Lee CY, Park SY, Shin TR, Park YB, Kim CH, Jang SH, Lee JW. Early-onset neutropenia during perioperative chemotherapy is predictive of increased survival in patients with completely resected non-small cell lung cancer: a retrospective analysis. Anticancer Res. 2013;33(6):2755-61.
  8. Lee JC, Jang SH, Lee KY, Kim YC. Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. Cancer Res Treat. 2013;45(2):79-85.
  9. Kim HR, Lee SY, Hyun DS, Lee MK, Lee HK, Choi CM, Yang SH, Kim YC, Lee YC, Kim SY, Jang SH, Lee JC, Lee KY. Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping. J Exp Clin Cancer Res. 2013;32(1):50.
  10. Koh WJ, Lee SH, Kang YA, Lee CH, Choi JC, Lee JH, Jang SH, Yoo KH, Jung KH, Kim KU, Choi SB, Ryu YJ, Kim KC, Um S, Kwon YS, Kim YH, Choi WI, Jeon K, Hwang YI, Kim SJ, Lee YS, Heo E, Lee J, Ki YW, Shim TS, Yim JJ. Comparison of Levofloxacin versus Moxifloxacin for Multidrug-Resistant Tuberculosis. Am J Respir Crit Care Med. 2013;188(7):858-864.
  11. Lee JY, Na II, Jang SH, Hwang YI, Choe du H, Kim CH, Baek H. Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers. J Thorac Dis. 2013;5(6):758-63
  12. Kim HR, Lee JC, Kim YC, Kim KS, Oh IJ, Lee SY, Jang TW, Lee MK, Shin KC, Lee GH, Ryu JS, Jang SH, Son JW, Lee JE, Kim SY, Kim HJ, Lee KY. Clinical characteristics of non-small cell lung cancer patients who experienced acquired resistance during gefitinib treatment. Lung Cancer. 2013 Lung Cancer. 2014;83(2):252-8.
  13. Jang SH. Long Term Therapeutic Plan for Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutation. Tuberc Respir Dis (Seoul). 2014 Jan;76(1):23-9
  14. Park S, Kim JH, Hwang YI, Jung KS, Jang YS, Jang SH. Schedule-dependent effect of epigallocatechin-3-gallate (EGCG) with paclitaxel on H460 cells. Tuberc Respir Dis 2014;76:114-119.
  15. Park TS, Kim HR, Koh JS, Jang SH, Hwang YI, Yoon HI, Chung JH, Kim CH, Kim SS, Kim WS, Jo J8, Lee JC, Choi CM. Heat shock protein 70 as a predictive marker for platinum-based adjuvant chemotherapy in patients with resected non-small cell lung cancer. Lung Cancer. Lung Cancer. 2014;86(2):262-7.
  16. Park C, Lee IJ, Jang SH, Lee JW. Factors affecting tumor recurrence after curative surgery for NSCLC: impacts of lymphovascular invasion on early tumor recurrence. J Thorac Dis. 2014;6(10):1420-8.
  17. Jang SH, Sheen S, Kim HY, Yim HW, Park BY, Kim JW, Park IK, Kim YW, Lee KY, Lee KS, Lee JM, Hwangbo B, Paik SH, Kim JH, Sung NJ, Lee SH, Hwang SS, Kim SY, Kim Y, Lee WC, Sung SW. The Korean guideline for lung cancer screening J Korean Med Assoc 2015;58(4):291-301. (2015년 4월)
  18. Kim HJ, Jang SH, Ryu JS, Lee JE, Kim YC, Lee MK, Jang TW, Lee SY, Nakamura H, Nishikata N, Mori M, Noguchi Y, Miyano H, Lee KY. The performance of a novel amino acid multivariate index for detecting lung cancer: A case control study in Korea. Lung Cancer. 2015;90(3):522-7
  19. Kang YA, Shim TS, Koh WJ, Lee SH, Lee CH, Choi JC, Lee JH, Jang SH, Yoo KH, Jung KH, Kim KU, Choi SB, Ryu YJ, Kim KC, Um S, Kwon YS, Kim YH, Choi WI, Jeon K, Hwang YI, Kim SJ, Lee HK, Heo E, Yim JJ. Choice between Levofloxacin and Moxifloxacin and Multidrug-Resistant Tuberculosis Treatment Outcomes. Ann Am Thorac Soc. 2016;13(3):364-70.
  20. Park JY, Jang SH. Epidemiology of Lung Cancer in Korea: Recent Trends. Tuberc Respir Dis (Seoul). 2016;79(2):58-69. Review.

김주희 조교수

  1. Palikhe NS, Kim JH, Park HS. Biomarkers predicting isocyanate-induced asthma. Allergy Asthma Immunol Res. 2011;3(1):21-6.
  2. Kim JH, Jin HJ, Nam YH, Park HS. Role of TSLP in Nasal Polyp Inflammation. Allergy Asthma Immunol Res. 2011;3(3):146-7.
  3. Kim JH, Kim JE, Choi GS, Kim HY, Ye YM, Park HS. Serum cytokines markers in toluene diisocyanate-induced asthma. Respir Med. 2011;105(7):1091-4.
  4. Kim JH, Jin HJ, Nam YH, Hwang EK, Ye YM, Park HS. Clinical features of allergic bronchopulmonary aspergillosis in Korea. Allergy Asthma Immunol Res. 2012;4(5):305-8.
  5. Nam YH, Kim JH, Jin HJ, Hwang EK, Shin YS, Ye YM, et al. Effects of omalizumab treatment in patients with refractory chronic urticaria. Allergy Asthma Immunol Res. 2012;4(6):357-61.
  6. Park HJ, Kim JH, Kim JE, Jin HJ, Choi GS, Ye YM, et al. Diagnostic value of the serum-specific IgE ratio of omega-5 gliadin to wheat in adult patients with wheat-induced anaphylaxis. Int Arch Allergy Immunol. 2012;157(2):147-50.
  7. Kim JH, Jang SH, Kim DH, Park S, Kim DG, Jung KS. A case of DRESS syndrome induced by the antituberculosis drugs, prothionamide, and para-aminosalycilic acid. Ann Allergy Asthma Immunol. 2013;110(2):118-9.
  8. Jung DM, Kim JH, Choi NY, Choi JH, Hwang YI, Jang SH, et al. Anaphylaxis associated with streptomycin skin testing. Ann Allergy Asthma Immunol. 2014;112(1):81-2.
  9. Kim JH, Choi GS, Kim JE, Jin HJ, Ye YM, Kim SH, et al. Clinical course of patients with aspirin-exacerbated respiratory disease: can we predict the prognosis? Pharmacogenomics. 2014;15(4):449-57.
  10. Kim JH, Park S, Hwang YI, Jang SH, Jung KS, Sim YS, et al. Immunoglobulin G Subclass Deficiencies in Adult Patients with Chronic Airway Diseases. J Korean Med Sci. 2016;31(10):1560-5.
  11. Kim SY, Kim JH, Jang YS, Choi JH, Park S, Hwang YI, et al. The Basophil Activation Test Is Safe and Useful for Confirming Drug-Induced Anaphylaxis. Allergy Asthma Immunol Res. 2016;8(6):541-4.